Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.51
Delayed Data
As of Apr 25
 -0.15 / -1.96%
Today’s Change
6.15
Today|||52-Week Range
11.34
-16.56%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +199.60% increase from the last price of 7.51.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$618.0K
Reporting Date
Apr 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -31.11%
 
 
 
 
 
 
Growthannually -50.96%
 
 
 
 
 
 

Sales

Growthquarterly 1.15%
 
 
 
 
 
 
Growthannually 7.21%
 
 
 
 
 
Key to the earnings and sales forecast charts.